Details.
A minimally invasive mitral valve replacement option for high surgical risk patients with symptomatic deterioration after tissue mitral valve replacement. The procedure may use access through the groin blood vessels or the chest and includes evaluation with cardiac CT and echocardiography, valve deployment, hospital monitoring for one to two days, and a comprehensive echocardiogram within 24 hours after the procedure.